Menu

Press Releases and Bulletins

SART and ASRM Issue Advice for Infertility Patients Concerning the Novel Coronavirus (COVID-19)

Patients, including prospective oocyte and sperm donors, as well as gestational carriers, who meet the diagnostic criteria for COVID-19 infection should avoid becoming pregnant. If they are undergoing active infertility treatment, we suggest that these patients consider freezing all oocytes or embryos and avoiding an embryo transfer until they are disease-free.

FDA Message on Coronavirus

The FDA continues to work closely with CDC and other federal and international agencies to monitor the evolving outbreak of the 2019 novel coronavirus (COVID-19) that was first identified in Wuhan, Hubei Province, China.

ASRM Joins Brief in Missouri Abortion Rights Case

ASRM has joined several leading national medical and public health organizations including AMA and ACOG, on an amicus brief in the United States Court of Appeals for the Eighth Circuit in the case of Reproductive Health Serices of Planned Parenthood of the St. Louis Regional, et al. V. Governor Michael L. Parson, et al.

New Jersey Strengthens Coverage for Infertility Treatment by Adding Fertility Preservation Law

New Jersey Governor Phil Murphy signed a fertility preservation mandate (S2133) into law today as part of a legislative package fighting New Jersey’s maternal and infant health crisis. This makes New Jersey the ninth state to pass a fertility preservation statute. This bill was intended to strengthen the 2017 update to New Jersey’s IVF mandate. The new law applies to health insurance policies and contracts that are delivered, renewed, extended, or modified in the state by any hospital service corporation, medical service corporation, health service corporation, health maintenance organization, or group health insurance policy with more than 50 people, as well as state and school employee’s health benefits commission.

ReproductiveFacts.org
is a patient education website of ASRM.
 


COVID-19 updates
Advocacy Day 2020